CITIGROUP INC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 181 filers reported holding NOVAVAX INC in Q1 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2019$174,000
-95.0%
315,418
-83.4%
0.00%
-100.0%
Q4 2018$3,497,000
+75.6%
1,900,595
+79.4%
0.00%
+50.0%
Q3 2018$1,992,000
+67.0%
1,059,247
+18.9%
0.00%
+100.0%
Q2 2018$1,193,000
-42.9%
891,018
-10.4%
0.00%
-50.0%
Q1 2018$2,089,000
+153.8%
994,597
+50.0%
0.00%
+100.0%
Q4 2017$823,000
+281.0%
663,244
+250.5%
0.00%
Q3 2017$216,000
+5.4%
189,212
+6.4%
0.00%
Q2 2017$205,000
-38.1%
177,895
-31.1%
0.00%
Q1 2017$331,000
-82.5%
258,224
-82.9%
0.00%
-100.0%
Q4 2016$1,896,000
+54.6%
1,505,747
+155.3%
0.00%0.0%
Q3 2016$1,226,000
-34.2%
589,782
+130.1%
0.00%
-50.0%
Q2 2016$1,864,000
-52.8%
256,371
-66.5%
0.00%
-50.0%
Q1 2016$3,952,000
+307.0%
765,833
+561.7%
0.00%
Q4 2015$971,000
-11.5%
115,735
-25.4%
0.00%
-100.0%
Q3 2015$1,097,000
+18.1%
155,161
+86.0%
0.00%0.0%
Q2 2015$929,000
+63.6%
83,431
+21.7%
0.00%0.0%
Q1 2015$568,000
-68.9%
68,568
-77.7%
0.00%
-50.0%
Q4 2014$1,828,000
+48.1%
308,157
+4.2%
0.00%
+100.0%
Q3 2014$1,234,000
+1032.1%
295,768
+1149.1%
0.00%
Q2 2014$109,000
-53.4%
23,679
-54.4%
0.00%
Q1 2014$234,000
-55.1%
51,889
-49.0%
0.00%
Q4 2013$521,000
+174.2%
101,658
+69.5%
0.00%
Q3 2013$190,000
+313.0%
59,986
+167.2%
0.00%
Q2 2013$46,00022,4490.00%
Other shareholders
NOVAVAX INC shareholders Q1 2016
NameSharesValueWeighting ↓
Caption Management, LLC 2,021,600$22,273,0001.23%
GREAT POINT PARTNERS LLC 4,500,000$2,479,0000.24%
SABBY MANAGEMENT, LLC 860,000$474,0000.23%
Sargent Investment Group, LLC 588,070$324,0000.16%
BB BIOTECH AG 8,330,000$4,589,0000.12%
GREAT POINT PARTNERS LLC 2,000,000$1,102,0000.11%
CENTAURUS FINANCIAL, INC. 7$12,000,0000.07%
Rock Springs Capital Management LP 3,250,000$1,790,0000.07%
Beirne Wealth Consulting Services, LLC 155,000$85,0000.07%
ACUTA CAPITAL PARTNERS, LLC 250,000$138,0000.07%
View complete list of NOVAVAX INC shareholders